Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • whuzzy
    Junior Member
    • Feb 2012
    • 1

    Tophat - aligning to known gene annotations

    Hi,

    I have a question about using TopHat. I want to map the reads only using known gene annotations (without discovering any novel splice junctions). Therefore I am using --GTF and --transcriptome-index options. However, I am not sure which option should I use --no-novel-juncs or --transcriptome-only and what is the difference between the two?

    For me it seems that whichever options I choose, TopHat still tries to map reads to genome (if they do not map to transcriptome). See below the log file from a run with --transcriptome-only option.

    ------------

    Mon Feb 6 22:18:11 2012] Preparing output location input/GM06985/tophat/
    [Mon Feb 6 22:18:11 2012] Checking for Bowtie index files
    [Mon Feb 6 22:18:11 2012] Checking for Bowtie index files
    [Mon Feb 6 22:18:11 2012] Checking for reference FASTA file
    [Mon Feb 6 22:18:11 2012] Checking for Bowtie
    Bowtie version: 0.12.7.0
    [Mon Feb 6 22:18:11 2012] Checking for Samtools
    Samtools Version: 0.1.16
    [Mon Feb 6 22:18:11 2012] Generating SAM header for hg19
    format: fastq
    quality scale: phred33 (default)
    [Mon Feb 6 22:18:35 2012] Reading known junctions from GTF file
    [Mon Feb 6 22:18:52 2012] Preparing reads
    left reads: min. length=50, count=38337749
    [Mon Feb 6 22:29:55 2012] Using pre-built transcriptome index..
    [Mon Feb 6 22:29:55 2012] Mapping left_kept_reads against transcriptome known with Bowtie
    [Mon Feb 6 23:19:26 2012] Converting left_kept_reads.m2g to genomic coordinates (map2gtf)
    [Mon Feb 6 23:54:00 2012] Resuming TopHat pipeline with unmapped reads
    [Mon Feb 6 23:54:00 2012] Mapping left_kept_reads.m2g_um against hg19 with Bowtie

    [Tue Feb 7 01:08:53 2012] Processing bowtie hits
    [Tue Feb 7 01:25:39 2012] Mapping left_kept_reads.m2g_um_seg1 against hg19 with Bowtie (1/2)
    [Tue Feb 7 02:20:36 2012] Mapping left_kept_reads.m2g_um_seg2 against hg19 with Bowtie (2/2)
    [Tue Feb 7 03:06:23 2012] Searching for junctions via segment mapping
    [Tue Feb 7 04:43:56 2012] Retrieving sequences for splices
    [Tue Feb 7 05:08:27 2012] Indexing splices
    [Tue Feb 7 05:19:54 2012] Mapping left_kept_reads.m2g_um_seg1 against segment_juncs with Bowtie (1/2)
    [Tue Feb 7 05:49:43 2012] Mapping left_kept_reads.m2g_um_seg2 against segment_juncs with Bowtie (2/2)
    [Tue Feb 7 06:17:11 2012] Joining segment hits
    [Tue Feb 7 06:36:14 2012] Reporting output tracks

Latest Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
    If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
    This guide explains everything you need to know about...
    Today, 01:13 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-02-2026, 11:08 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Working...